Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $21.3 million.

  • Cellebrite DI's Net Income towards Common Stockholders rose 1033.78% to $21.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $78.3 million, marking a year-over-year increase of 12792.86%. This contributed to the annual value of $78.3 million for FY2025, which is 12767.63% up from last year.
  • According to the latest figures from Q4 2025, Cellebrite DI's Net Income towards Common Stockholders is $21.3 million, which was up 1033.78% from $20.2 million recorded in Q3 2025.
  • Cellebrite DI's 5-year Net Income towards Common Stockholders high stood at $54.5 million for Q1 2022, and its period low was -$204.5 million during Q3 2024.
  • In the last 5 years, Cellebrite DI's Net Income towards Common Stockholders had a median value of $8.6 million in 2021 and averaged -$4.3 million.
  • As far as peak fluctuations go, Cellebrite DI's Net Income towards Common Stockholders surged by 165595.8% in 2021, and later tumbled by 308637.76% in 2024.
  • Cellebrite DI's Net Income towards Common Stockholders (Quarter) stood at $51.9 million in 2021, then plummeted by 82.45% to $9.1 million in 2022, then crashed by 235.63% to -$12.3 million in 2023, then surged by 256.09% to $19.3 million in 2024, then increased by 10.34% to $21.3 million in 2025.
  • Its Net Income towards Common Stockholders was $21.3 million in Q4 2025, compared to $20.2 million in Q3 2025 and $19.5 million in Q2 2025.